• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Arkray inks licensing deal with Mellitus Health for insulin titration software

January 31, 2018 By Sarah Faulkner

diabetesArkray‘s U.S. business has inked a licensing deal with Mellitus Health for its insulin titration software, Insulin Insights.

Mellitus Health, formerly known as Insulin Algorithms, developed the clinical decision-support tool to help doctors keep their patients’ blood sugar levels in control with optimized insulin therapy. The software is compatible with any blood glucose monitoring system and with all brands of insulin.

According to the deal, Arkray plans to integrate Insulin Insights into its suite of diabetes products.

“Mellitus Health’s software unlocks the value of glucose monitor data to make life easier for clinicians, save money for insurers and managed care providers, and—most importantly—improve health outcomes for patients using our Glucocard and ReliOn branded blood glucose meters,” Jonathan Chapman, President of Arkray USA, said in prepared remarks. “Our partnership with Mellitus Health has the potential to significantly improve diabetes clinical care.”

“We designed Insulin Insights to address the diabetes care gap, which is the failure of health care systems to meet the clinical needs of the growing diabetic population,” Mellitus Health CEO Josh Davidson added.

“Ninety percent of diabetics are treated by primary care physicians because of the massive shortage of endocrinologists. Insulin Insights mitigates this problem by giving these and other clinicians, including nurses and physician assistants, the ability to provide the regular insulin dose adjustments needed to maintain blood sugar control. We look forward to working with Arkray as they share our vision of improving the care of the diabetic patient by creating an end-to-end solution from patient to clinician.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: arkray, mellitushealth

IN CASE YOU MISSED IT

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Abbott could pave new roads in diabetes management with dual sensor on the horizon

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS